S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

VTGN Vistagen Therapeutics Inc

2.85

-0.07 (-2.40%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Vistagen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Vistagen Therapeutics Charts.

Vistagen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Vistagen Therapeutics Charts.

Vistagen Therapeutics Inc News

Form 8-K - Current report
Tuesday 14 January 2025 (3 days ago) • Edgar (US Regulatory)

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia
Tuesday 14 January 2025 (4 days ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (4 days ago) • Edgar (US Regulatory)

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder
Friday 10 January 2025 (1 week ago) • Business Wire

Form 8-K - Current report
Friday 6 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Vistagen to Present at the Stifel 2024 Healthcare Conference
Thursday 14 November 2024 (2 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
Thursday 7 November 2024 (2 months ago) • Business Wire

More Vistagen Therapeutics Inc News Articles

MineralRite (PK)

TheGlobe com (PK)

RespireRx Pharmaceuticals (CE)

UAV Corpoation (PK)

Good Vibrations Shoes (PK)

GBT Technologies (PK)

Bioelectronics (PK)

TPT Global Tech (CE)

Rennova Health (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions